An interventional study of Integrated Community Engagement Collaborative and School-Based Data Collection and Reporting without Network Coordinator Support in Substance Use (Drugs, Alcohol), Tobacco Use and Adolescent Substance Use, sponsored by West Virginia University. Not yet recruiting at 1 site in United States. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by West Virginia University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,589 studies in Substance-Related Disorders with a site in United States — 249 open to participants now, 313 under way, 4 of them phase 3. Substance-Related Disorders · United States.
Among the 1,589 studies in Substance-Related Disorders with a site in United States, this one is the 4th largest by planned enrollment of the 1,447 interventional ones that give a count, is one of 93 that started in 2026, is one of 958 with no phase, reaches primary completion later than 288 of the 312 other live ones, and was the 1,577th registered.
2,242 studies on the registry are indexed under Substance-Related Disorders; 408 are open to participants now.
Browse Substance-Related Disorders studies →249 of the 1,589 studies in Substance-Related Disorders with a site in United States are open now. Recruiting first, the newest first:
Emory University · Sites in United States
Ages 18+ · Healthy volunteers
National Institute on Drug Abuse (NIDA) · Sites in United States
Ages 18–120
National Institute on Drug Abuse (NIDA) · Sites in United States
Ages 18–65 · Healthy volunteers
University of Massachusetts, Worcester · Sites in United States
Ages 18+
University of Texas Southwestern Medical Center · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 266 Substance-Related Disorders studies recruiting now, 130 (49%) set no upper age limit and 117 (44%) stop at 75 or younger; 55 take children under 18; 90 take healthy volunteers.
This study: 10 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,589 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 172 · Phase 2 242 · Phase 3 79 · Phase 4 67
First in 1990; this study’s year is marked. 93 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 25,000 is above the median of 108 across 1,844 interventional studies indexed under Substance-Related Disorders.
Median enrollment 104 across the 1,447 interventional studies, 234 across the 137 observational. Of the 1,175 that completed or were terminated, 376 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
83 of 1,589 have an industry lead sponsor. The 10 most frequent:
West Virginia University is the lead sponsor of 157 studies on the registry; 36 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 16 (84%) have results posted.
West Virginia University has 5 studies filed under Substance-Related Disorders — fewer than ten, so there is no comparison to draw.
100 of the studies in Substance-Related Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07566273Cornell UniversityMicropractices for Unhoused LGBTQ Youth | 2026-11 |
| NCT05897164Evidence-Based Practice Institute, Seattle, WAMobile Technology to Reduce Teen Substance Misuse | 2026-11-30 |
| NCT04317482University of ArkansasThe Human Stress Response in a Simulated ED Setting | 2026-12 |
| NCT05713695University of Massachusetts, WorcesterSupporting Treatment Access and Recovery Through Linkage and Support | 2026-12 |
| NCT03539575Yale UniversityCB1R in Synthetic Psychoactive Cannabinoids | 2026-12 |
Add all 100 to your calendar (.ics) → With an account.
Among the 1,589 studies in Substance-Related Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate whether the Integrated Community Engagement (ICE) Collaborative can help prevent alcohol, tobacco, and other drug use among youth living in rural communities. The study is coordinated through the West Virginia University Prevention Research Center and will be conducted in participating public schools and County Prevention Coalitions located in up to 36 rural counties in West Virginia. Students in grades 7 through 12 at participating public schools will complete confidential online surveys once each year for four years. The surveys will assess alcohol, tobacco, and other drug use, as well as family, peer, school, and community factors that may increase or decrease the risk of substance use. All participating counties will receive reports summarizing these survey results at the school and county levels.
Counties will be randomly assigned to one of two groups. Counties in the intervention group will receive support from trained Network Coordinators who will work with local County Prevention Coalitions to review community data, engage local stakeholders, develop action plans, strengthen prevention efforts, and support implementation of community-selected prevention strategies. Counties in the comparison group will receive survey reports but will not receive this implementation support. The researchers will compare the two groups to determine whether the ICE Collaborative reduces youth alcohol, tobacco, and other drug use and improves community factors that support healthy youth development. The study will also evaluate whether the intervention strengthens community prevention coalitions, stakeholder engagement, resource development, and implementation of prevention programs and policies
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Counties assigned to this arm will participate in the Integrated Community Engagement (ICE) Collaborative. Students in grades 7 through 12 will complete annual confidential surveys, and counties will receive school-level and county-level reports summarizing alcohol, tobacco, and other drug use and associated risk and protective factors. County Prevention Coalitions will receive implementation support from Network Coordinators, including coalition development, stakeholder engagement, dissemination and interpretation of local data, strategic planning, resource development, and support for implementation of locally selected prevention strategies through a structured community engagement process
Other: Integrated Community Engagement Collaborative
Counties assigned to this arm will participate in annual school-based surveys of students in grades 7 through 12 and will receive school-level and county-level reports describing alcohol, tobacco, and other drug use and associated risk and protective factors. Counties in this arm will not receive Network Coordinator support, coalition capacity-building activities, technical assistance, or implementation support provided through the Integrated Community Engagement Collaborative.
Other: School-Based Data Collection and Reporting without Network Coordinator Support
The Integrated Community Engagement (ICE) Collaborative is a community capacity-building framework designed to strengthen local prevention systems and reduce youth alcohol, tobacco, and other drug use. The intervention includes annual collection and dissemination of youth survey data, coalition development, stakeholder engagement, data-driven decision making, strategic planning, technical assistance, resource development, and implementation support. Network Coordinators housed within Regional Prevention Lead Organizations provide ongoing support to County Prevention Coalitions to facilitate community-driven prevention planning and implementation. Counties participate in repeated annual implementation cycles throughout the study period.
Also known as: ICE Collaborative
Annual collection of confidential school-based survey data from students in grades 7 through 12 and dissemination of school-level and county-level reports describing alcohol, tobacco, and other drug use and associated risk and protective factors. Counties assigned to this condition receive data reports but do not receive implementation support, technical assistance, coalition development activities, or Network Coordinator assistance.
Change in Past 30-Day Alcohol, Tobacco, and Other Drug (ATOD) Use Prevalence
Past 30-day prevalence of tobacco cigarette use, electronic cigarette use, alcohol use, drunkenness, and cannabis use among students in grades 7 through 12 will be assessed using annual school-based online surveys. Tobacco and e-cigarette use will be assessed on a 7-point scale ranging from 1=Never used, to 7=More than 20 times per day. Alcohol, drunkenness, and cannabis use will be assessed on a 7-point count scale ranging from 1=0 times, to 7=40 times+. Outcomes will be reported separately as the percentage of students reporting each substance use behavior during the previous 30 days. Higher percentages indicate greater substance use prevalence.
Time frame: Baseline and Annually through Year 5
Change in Lifetime Alcohol, Tobacco, and Other Drug (ATOD) Use Prevalence
Lifetime prevalence of tobacco cigarette use, electronic cigarette use, alcohol use, drunkenness, and cannabis use among students in grades 7 through 12 will be assessed using annual school-based online surveys. Outcomes will be reported separately as the percentage of students reporting lifetime use of each substance or behavior. Scoring for each of those variables will range from 1=0 times, to 7= 40 times+. Higher percentages indicate greater lifetime substance use prevalence.
Time frame: Baseline and Annually through Year 5
Change in Family Risk and Protective Factors
Family-domain scores will be assessed annually using student surveys measuring seven concepts: perceived parental support, family social support, time spent with parents, parental monitoring, social capital, parental reactions to substance use, and parental/sibling substance use. Composite scores will be calculated as follows: perceived parental support (5 items, 4-point Likert, range 4-20); family social support (3 items, 7-point Likert, range 3-21); time spent with parents (2 items, 5-point Likert, range 2-10); parental monitoring (2 items, 4-point Likert, range 2-8); social capital (2 items, 4-point Likert, range 2-8); parental reactions to substance use (5 items, 4-point Likert, range 4-16); and parental/sibling substance use (3 yes/no items). Higher scores on protective-factor measures indicate greater protection against youth substance use, while higher scores on risk-factor measures indicate greater exposure to substance use risk.
Time frame: Baseline and annually through Year 5
Change in Peer Risk and Protective Factors
Peer-domain scores will be assessed annually using student surveys measuring five concepts: friend social support, peer substance use, peer delinquency, perceived peer respect for substance use, and perceived peer respect for delinquency. Composite scores will be calculated as follows: friend social support (3 items, 7-point Likert scale, range 3-21); peer substance use (5 items, 5-point Likert scale, range 5-25); peer delinquency (3 items, 5-point Likert scale, range 3-15); perceived peer respect for substance use (5 items, 5-point Likert scale, range 5-25); and perceived peer respect for delinquency (3 items, 5-point Likert scale, range 3-15). Higher scores on protective-factor measures indicate greater protection against youth substance use, while higher scores on risk-factor measures indicate greater exposure to substance use risk.
Time frame: Baseline and Annually through Year 5
Change in School Risk and Protective Factors
School-domain scores will be assessed annually using student surveys measuring five concepts: supportive adults in school, supportive peers in school, motivation to learn and grow, school connectedness, and school absenteeism. Composite scores will be calculated as follows: supportive adults in school (5 items, 5-point Likert scale, range 5-25); supportive peers in school (4 items, 5-point Likert scale, range 4-20); motivation to learn and grow (5 items, 5-point Likert scale, range 5-25); school connectedness (composite score derived from survey items); and school absenteeism (2 items, 6-point count scale, range 2-12, with response options from none to 7 or more days). Higher scores on protective-factor measures indicate greater protection against youth substance use, while higher scores on risk-factor measures indicate greater exposure to substance use risk.
Time frame: Baseline and Annually through Year 5
Change in Leisure-Time Risk and Protective Factors
Leisure-time domain scores will be assessed annually using student surveys measuring three concepts: late outside hours, structured recreational activities, and unstructured activities. Composite scores will be calculated as follows: late outside hours (2 items, 8-point count scale, range 2-16, with responses from never to 7 or more days); structured recreational activities (7 items, 9-point frequency scale, range 7-63, with responses from less than once per week to seven times per week); and unstructured activities (6 items, 5-point frequency scale, range 6-30, with responses from never to four or more times per week). Higher scores on protective-factor measures indicate greater protection against youth substance use, while higher scores on risk-factor measures indicate greater exposure to substance use risk.
Time frame: Baseline and Annually through Year 5
Change in Implementation Integrity and Consistency
Implementation integrity and consistency will be assessed using the ICE Implementation Integrity and Consistency Assessment (ICE-IICA). Scores from 126 yes/no questions (scored 0/1) represent the percentage of required implementation activities completed across the ICE implementation process within each county. Higher scores indicate greater adherence to and consistency of implementation.
Time frame: Baseline and Annually through Year 5
Change in Role Structure and Clarity- Efficient Practices
County Prevention Coalition Role structure and clarity will be assessed using the Efficient Practices subscale of the Internal Coalition Effectiveness Instrument (ICEI). Higher scores indicate more efficient coalition practices.
Time frame: Baseline and Annually through Year 5
Change in Role Structure and Clarity- Coalition Efficiency Subscale
County Prevention Coalition Role structure and clarity will be assessed using the Coalition Efficiency subscale of the Communities That Care Coalition Functioning Survey (CFS). Higher scores indicate clearer coalition roles.
Time frame: Baseline and Annually through Year 5
Change in Cohesion and Collaboration- Relationship and Participation
County Prevention Coalition Cohesion and collaboration will be assessed using 10 items from the Relationships and Participation subscales of the Internal Coalition Effectiveness Instrument (ICEI). Higher scores indicate greater levels of collaboration, teamwork, and coalition member relationships.
Time frame: Baseline and Annually through Year 5
Change in Cohesion and Collaboration- CFS Cohesion and Participation Benefits
County Prevention Coalition Cohesion and collaboration will be assessed using the Cohesion and Participation Benefits subscales of the Communities That Care Coalition Functioning Survey (CFS) measured on a 5-point Likert scale with a total range from 10-50. Higher scores indicate greater cohesion and perceived benefits of participation.
Time frame: Baseline and Annually through Year 5
Change in Relational Coordination
County Prevention Coalition Relational coordination will be assessed using 6 items the Relational Coordination Survey measured on a 5-point Likert scale with a total range from 6-30. Higher scores indicate stronger communication, shared goals, shared knowledge, and mutual respect among coalition members and partner organizations.
Time frame: Baseline and Annually through Year 5
Change in Strategic Planning Capacity
County Prevention Coalition Relational coordination will be assessed using 6 items the Relational Coordination Survey measured on a 5-point Likert scale with a total range from 6-30. Higher scores indicate stronger communication, shared goals, shared knowledge, and mutual respect among coalition members and partner organizations.
Time frame: Baseline and Annually through Year 5
Change in Stakeholder Engagement
County Prevention Coalition Stakeholder engagement will be assessed using the Community Impact Scale (CIS) and coalition records documenting stakeholder participation. The CIS assesses stakeholder satisfaction, perceived benefits, motivation, engagement, and knowledge gained measured on a 5-point Likert scale with a total range from 10-50. Higher scores indicate greater stakeholder involvement and engagement in coalition activities.
Time frame: Baseline and Annually through Year 5
Change in Data-Driven Decision-Making Capacity
County Prevention Coalition Data-driven decision-making capacity will be assessed using an adapted version of the 3D-ME Inventory, the Data-Driven Decision-Making Questionnaire (DDDM-Q), and coalition records documenting dissemination and use of local survey data. In total 9 items will be applied and scored on a 5-point Likert scale with a range between 9 and 45. Higher scores indicate greater capacity to use data to guide coalition planning, resource allocation, and implementation decisions.
Time frame: Baseline and Annually through Year 5
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Jul 2030, 45 months later.
Of 819 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 45 months is above that.
Counting every sponsor, half of 859 studies reached it within 34 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.